Welcome to LookChem.com Sign In|Join Free

CAS

  • or

695172-02-2

Post Buying Request

695172-02-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

695172-02-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 695172-02-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,5,1,7 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 695172-02:
(8*6)+(7*9)+(6*5)+(5*1)+(4*7)+(3*2)+(2*0)+(1*2)=182
182 % 10 = 2
So 695172-02-2 is a valid CAS Registry Number.

695172-02-2Relevant articles and documents

The first potent diphenyl phosphonate KLK4 inhibitors with unexpected binding kinetics

Van Soom, Jeroen,Cuzzucoli Crucitti, Giuliana,Gladysz, Rafaela,Van Der Veken, Pieter,Di Santo, Roberto,Stuyver, Ingmar,Buck, Victoria,Lambeir, Anne-Marie,Magdolen, Viktor,Joossens, Jurgen,Augustyns, Koen

, p. 1954 - 1958 (2015/11/17)

KLK4 is a serine protease from the kallikrein family that is involved in cancer progression. The diphenyl phosphonate warhead is intended to bind irreversibly with serine proteases, but unexpectedly, very potent KLK4 diphenyl phosphonate inhibitors were d

A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression

Chitneni, Satish K.,Deroose, Christophe M.,Balzarini, Jan,Gijsbers, Rik,Celen, Sofie,Debyser, Zeger,Mortelmans, Luc,Verbruggen, Alfons M.,Bormans, Guy M.

, p. 6627 - 6637 (2008/09/17)

We recently reported a new positron emission tomography (PET) reporter gene, namely, varicella-zoster virus thymidine kinase (VZV-tk) in combination, with carbon-11 or fluorine-18 labeled m-alkoxyphenyl bicyclic nucleoside analogues (BCNAs) as PET reporte

NOVEL UROKINASE INHIBITORS

-

Page/Page column 81-83; 85-86, (2010/11/27)

The present invention relates to novel compounds with inhibitory activity towards urokinase plasminogen activator (uPA); to methods for preparation of said uPA inhibitor compounds; to pharmaceutical compositions comprising said uPA inhibitor compounds; to

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 695172-02-2